Care must be taken in interpreting reports of ‘malignancy-associated TTP’ in the literature, as these simply reflect cases of TMA with features similar to TTP, with no reported severe ADAMTS13 deficiency or with no ADAMTS13 testing being performed to clarify this specific diagnosis [59,60,61,62]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.